Rapid diagnostic screening is an unmet need in patients with suspected cardiomyopathy (CM). The authors recently demonstrated in a retrospective study that magnetocardiography (MCG) may be a suitable tool to detect CM. This study aims to prospectively evaluate the accuracy of MCG as a screening tool in patients with suspected CM. MCG offers a noninvasive, reproducible methodology for rapid and accurate detection of CM after exclusion of ischemic heart disease. Our data indicate that MCG may be an efficient tool for allocation of advanced imaging to those patients with a high likelihood of disease. 

Read full article (JACC Heart Fail. 2026;14(8):103182) here!